- Home
- CLDI vs NCPL Comparison
CLDI vs NCPL Comparison
Compare CLDI & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- NCPL
- Stock Information
- Founded
- CLDI 2014
- NCPL 1984
- Country
- CLDI United States
- NCPL United States
- Employees
- CLDI N/A
- NCPL N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- NCPL Investment Managers
- Sector
- CLDI Health Care
- NCPL Finance
- Exchange
- CLDI Nasdaq
- NCPL Nasdaq
- Market Cap
- CLDI 8.7M
- NCPL 9.1M
- IPO Year
- CLDI N/A
- NCPL N/A
- Fundamental
- Price
- CLDI $1.58
- NCPL $2.24
- Analyst Decision
- CLDI
- NCPL
- Analyst Count
- CLDI 0
- NCPL 0
- Target Price
- CLDI N/A
- NCPL N/A
- AVG Volume (30 Days)
- CLDI 161.6K
- NCPL 111.9K
- Earning Date
- CLDI 11-11-2025
- NCPL 09-22-2025
- Dividend Yield
- CLDI N/A
- NCPL N/A
- EPS Growth
- CLDI N/A
- NCPL N/A
- EPS
- CLDI N/A
- NCPL N/A
- Revenue
- CLDI N/A
- NCPL $917,291.00
- Revenue This Year
- CLDI N/A
- NCPL $739.37
- Revenue Next Year
- CLDI N/A
- NCPL N/A
- P/E Ratio
- CLDI N/A
- NCPL N/A
- Revenue Growth
- CLDI N/A
- NCPL N/A
- 52 Week Low
- CLDI $1.41
- NCPL $1.41
- 52 Week High
- CLDI $46.68
- NCPL $8.75
- Technical
- Relative Strength Index (RSI)
- CLDI 44.14
- NCPL 43.90
- Support Level
- CLDI $1.51
- NCPL $2.20
- Resistance Level
- CLDI $1.74
- NCPL $2.41
- Average True Range (ATR)
- CLDI 0.10
- NCPL 0.15
- MACD
- CLDI 0.04
- NCPL -0.01
- Stochastic Oscillator
- CLDI 30.43
- NCPL 7.27
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.